Dear All,
Please find attached, for your information, the press releases which were published at the occasion of the 2008 EULAR (European League Against Rheumatism) congress in Paris.
- CIMZIA® IS THE FIRST ANTI-TNF SHOWN TO INHIBIT PROGRESSION OF JOINT DAMAGE AS EARLY AS 16 WEEKS IN RHEUMATOID ARTHRITIS
- EPRATUZUMAB REDUCED DISEASE ACTIVITY AND STEROID USE IN PATIENTS WITH MODERATE AND SEVERE FLARING SLE
Best regards,
UCB Investor Relations Team
